The MarketWatch News Department was not involved in the creation of this content. -Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: ...
Modular Medical ( ($MODD) ) just unveiled an announcement. On June 30, 2025, Modular Medical disclosed that its shares had traded below Nasdaq’s ...
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA, CA / ACCESS Newswire / October 6, 2025 ...
Modular Medical (MODD) received written notification from the Listing Qualifications Department of the Nasdaq Stock Market, granting the Company’s ...
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...
SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 ...
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump Modular Medical's second-generation tubeless platform, its Pivot pump, builds on the Company's FDA-cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback